NCT05068271

Brief Summary

The current project utilizes a single-blinded, double arm, 6-month randomized controlled trial to assess the effects of a multi-domain exercise program on memory performance, as well as cortical activities during the memory tasks in cognitively intact adults (i.e., 45-70 years). In addition, the potential moderator role of apolipoprotein epsilon-4 (ApoE e4) status and the mediator role of the brain-derived neurotrophic factor (BDNF) will be explored.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 5, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

April 12, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

2.9 years

First QC Date

July 19, 2021

Last Update Submit

November 23, 2023

Conditions

Keywords

multiple fitnessmeditationmindfulnessApolipoprotein Eagingmagnetic resonance imagesmemory

Outcome Measures

Primary Outcomes (3)

  • Changes in functional MRI indices

    Functional MRI assessments will be conducted at the baseline (Baseline-Assessment) and at the end of the 6-month intervention (Post-Assessment) to measure participants' brain functionalities. Changes in functional MRI indices between the Baseline-Assessment and Post-Assessment will be assessed.

    60 min each at the Baseline-Assessment and at the Post-Assessment

  • Changes in working memory performance: N-back working memory task

    Working memory performance will be assessed using the computerized n-back working memory task at the baseline (Baseline-Assessment) and at the end of the 6-month intervention (Post-Assessment). A total of 6 blocks with 108 trials (18 trials each block) will be utilized in the current study. Changes in working memory performance between the Baseline-Assessment and Post-Assessment will be assessed.

    30 min assessment time at the Baseline-Assessment and at the Post-Assessment

  • Changes in episodic memory performance: Relational and item-specific encoding and recognition test

    Episodic memory performance will be assessed using the relational and item-specific encoding and recognition test at the baseline (Baseline-Assessment) and at the end of the 6-month intervention (Post-Assessment). Changes in episodic memory performance between the Baseline-Assessment and Post-Assessment will be assessed.

    30 min each session at the Baseline-Assessment and at the Post-Assessment

Secondary Outcomes (10)

  • ApoE genotype

    5 min at the Baseline Assessment

  • Changes in blood neurotrophic marker: Brain-derived neurotrophic factor (BDNF)

    5 min each at the Baseline-Assessment and at the Post-Assessment

  • Physical fitness measurements: Changes in aerobic fitness

    20 min each at the Baseline-Assessment and at the Post-Assessment

  • Physical fitness measurements: Changes in muscular fitness

    15 min each at the Baseline-Assessment and at the Post-Assessment

  • Physical fitness measurements: Changes in flexibility

    15 min each at the Baseline-Assessment and at the Post-Assessment

  • +5 more secondary outcomes

Study Arms (2)

Multi-Domain Exercise Program

EXPERIMENTAL

Time: 6 months, total of 150 min of exercise per week. Intervention: aerobic training, muscular fitness training, balance, flexibility, meditation, and social interaction.

Behavioral: Multi-Domain Exercise Program

Control Group

OTHER

Time: 6 months, total of 60 min of online educational course per week. Intervention: educational materials relating to the effects of exercise on cognitive function and aging-related cognitive decline.

Behavioral: Control Group

Interventions

The multi-domain exercise consisted of the main exercise (e.g., aerobic exercise, resistance exercise, flexibility training, and coordinative exercise), social interaction, and meditation. Participants are encouraged to engage in 150 min exercise per week consisting of one 90-min on-site session and multiple online sessions for 6 months.

Multi-Domain Exercise Program
Control GroupBEHAVIORAL

The "usual physical activity group," as the control group, is informed to maintain their lifestyles. In addition, participants are invited to attend one 60-min online educational course per week. The logs of physical activity behavior will be obtained from the participants once per month during the intervention period.

Control Group

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal or corrected-to-normal vision
  • Able to speak and read Chinese
  • Scores of Mini-Mental Status Examination \>= 25
  • Physical Activity Readiness Questionnaire score \< 0
  • Able to conduct the exercise with moderate intensity
  • Meet the criteria to undergo magnetic resonance imaging
  • Provide informed consent

You may not qualify if:

  • Diagnosed or self-reported cognitive problems (e.g., mild cognitive impairment or dementia)
  • Diagnosed or self-reported physical disease (e.g., untreated hypertension and chronic heart disease, stroke, brain tumor, musculoskeletal disorders, other exercise contradictions)
  • Diagnosed or self-reported major psychiatric illness (e.g., major depression, schizophrenia)
  • Diagnosed or self-reported neurodegenerative disease (e.g., Alzheimer's disease and other dementias, Parkinson's disease (PD) and PD-related disorders, Huntington's disease)
  • History of alcohol or drug abuse
  • History of chemotherapy
  • Traveling consecutively for three weeks or more during the study
  • Unwillingness to be randomized to one of the two groups
  • Currently participating in another study trial
  • Participants will be excluded if s/he has a contraindication to fMRI scanning, such as aneurysm clip, implanted neural stimulator, cochlear implant, any implanted device, cardiac pacemaker. To ensure volunteers are eligible for the current project, they will be asked to fill out a questionnaire to inform whether they have conditions (e.g. paralyzed hemidiaphragm) or present unnecessary risks (e.g., pregnancy) during the recruitment period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yu-Kai Chang

Taipei, 106, Taiwan

NOT YET RECRUITING

National Taiwan Normal University

Taipei, 162, Taiwan

RECRUITING

Related Publications (1)

  • Chang YK, Erickson KI, Aghjayan SL, Chen FT, Li RH, Shih JR, Chang SH, Huang CM, Chu CH. The multi-domain exercise intervention for memory and brain function in late middle-aged and older adults at risk for Alzheimer's disease: A protocol for Western-Eastern Brain Fitness Integration Training trial. Front Aging Neurosci. 2022 Aug 18;14:929789. doi: 10.3389/fnagi.2022.929789. eCollection 2022.

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Yu-Kai Chang, PhD

    Department of Physical Education and Sport Sciences, National Taiwan Normal University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu-Kai Chang, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 19, 2021

First Posted

October 5, 2021

Study Start

April 12, 2022

Primary Completion

March 1, 2025

Study Completion

September 1, 2025

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations